Muscle-invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Muscle-invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy [Phase 2]
Phase 2 trial investigating nivolumab with chemoradiotherapy for muscle-invasive bladder cancer in patients not undergoing cystectomy.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder [Phase 2]
Phase 2 study evaluating neoadjuvant gemcitabine/platinum chemotherapy for muscle-invasive or locally-advanced urothelial carcinoma of the b…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of oral APL-1202 in combination with tislelizumab vs tislelizumab alone as neoadjuvant t…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma [Phase 2]
Phase 2 study update on neoadjuvant dose-dense MVAC therapy for muscle-invasive bladder cancer and locally advanced urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy [Phase 2]
Phase 2 trial update for Nivolumab plus Gemcitabine and Cisplatin in muscle invasive bladder cancer undergoing cystectomy has completed with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer [Phase 1]
Phase Ib feasibility neoadjuvant trial of nivolumab plus lirilumab for cisplatin-ineligible muscle-invasive bladder cancer has completed enr…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating avelumab with fluorouracil and mitomycin or with cisplatin and radiation therapy for muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial of rucaparib in locally advanced or metastatic urothelial carcinoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial of avelumab in non-metastatic muscle-invasive bladder cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer [NA]
Clinical trial comparing radical cystectomy to chemoradiation for muscle invasive bladder cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant dose-dense gemcitabine and cisplatin trial in muscle-invasive bladder cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial exploring pegylated liposomal doxorubicin with a PD-1 inhibitor for muscle invasive bladder cancer is in progress, status curr…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Dose Dense MVAC for Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update for dose-dense MVAC chemotherapy in muscle invasive bladder cancer and high-risk urothelial carcinoma of the upper urin…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating paclitaxel-binding albumin and cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy [NA]
A terminated clinical trial investigating chemoradiation for bladder preservation after complete response to neoadjuvant chemotherapy in bla…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer [Phase 2]
Phase 2 study investigating trimodal therapy with atezolizumab in muscle-invasive bladder cancer; status is unknown. Focuses on safety issue…
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluated erlotinib as neoadjuvant and adjuvant therapy around surgery for muscle-invasive bladder cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine hydrochloride and cisplatin before surgery in patients with muscle invasive bladder cancer was termin…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer [NA]
This clinical trial evaluated the feasibility of online adaptive radiotherapy for muscle-invasive bladder cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin [Phase 2]
Phase 2 neoadjuvant gemcitabine plus weekly cisplatin for muscle-invasive bladder cancer (including patients not candidates for high-dose ci…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant chemotherapy trial evaluating gemcitabine, cisplatin, and sunitinib (GC-S) for muscle-invasive bladder cancer; study com…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine, carboplatin, and panitumumab (GCaP) as neoadjuvant chemotherapy for muscle-invasive bladder cancer w…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma [Phase 2]
Phase 2 study of dose-dense MVAC chemotherapy with pegfilgrastim support in patients with muscle-invasive bladder cancer; results were poste…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer [NA]
Completed safety and tolerability trial evaluating intravesical mitomycin C mixed with a TC-3 drug-retaining hydrogel device in patients wit…